Resources from the same session
LBA2 - Analytical and clinical validation of a ctDNA-based assay for multi-cancer detection
Presenter: Le Son Tran
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
1MO - Image biomarker discovery from DCE-MRI for identifying responders of MK-2206 on early-stage breast cancer patients: A secondary radio-genomics analysis of I-SPY2 trial
Presenter: Jiang Zhang
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
56MO - Landscape of ESR1 mutations in advanced breast cancer using circulating tumor DNA (ctDNA) next-generation sequencing (NGS) in Asia and Middle East (AME)
Presenter: Shaheenah Dawood
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Breast cancer
Resources:
Webcast
2MO - Multimodal data fusion enhanced precision neoadjuvant chemotherapy in breast cancer with a multi-task transformer-CNN-mixed learning
Presenter: Yunfang Yu
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
3MO - Multimodal data fusion for improved risk stratification of breast cancer with multi-task 3D deep learning model: A multicenter study
Presenter: Wei Ren
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
4MO - A prediction model for developing lymphedema in breast cancer patients receiving sentinel node biopsy
Presenter: Jin Young Byeon
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Breast cancer
Resources:
Webcast
LBA3 - Phase III study of neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for early-stage triple-negative breast cancer (TNBC): KEYNOTE-522 Korean subgroup analysis
Presenter: Jin-Hee Ahn
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
LBA6 - A phase II, single arm, open label, Simon two-stage study of pembrolizumab in metastatic HER2-negative breast cancer patients: Evaluation of impact of germline variants in APOBEC3B (AUROR)
Presenter: Gwo Fuang Ho
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast